Grant of Stock Options under Gland Pharma Employee Stock Option Scheme 2025
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gland Pharma's ESOP Compensation Committee has approved the grant of 690,019 employee stock options to 124 employees under the ESOP 2025 scheme. Of the total options, 455,413 options are priced at INR 934.15 each (50% of the NSE closing price on May 15, 2026), while 234,606 options are priced at INR 1 (face value). The options will vest over three years: 34% after the first year (May 2027), 33% after the second year (May 2028), and 33% after the third year (May 2029). Employees can exercise these options within two years from the vesting date. The grant complies with SEBI (Share Based Employee Benefits & Sweat Equity) Regulations, 2021.
This ESOP grant aligns employee interests with shareholders and helps retain talent, which could support long-term performance. The dilutive impact is limited given the vesting schedule spread over three years, with no immediate shareholder dilution.